What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His main research concerns Pathology, Cancer research, Immunohistochemistry, Epstein–Barr virus and Carcinoma.
His Pathology research is multidisciplinary, incorporating perspectives in Hepatocellular carcinoma, Metastasis and Adenocarcinoma.
His study in Cancer research is interdisciplinary in nature, drawing from both Carcinogenesis, Cancer, Methylation, Gene and DNA methylation.
His DNA methylation research is multidisciplinary, relying on both Promoter, Regulation of gene expression and Epigenetics.
His Immunohistochemistry research integrates issues from PDGFRA Gene Mutation, PDGFRA, Gene rearrangement, Differential diagnosis and Lung cancer.
His studies in Carcinoma integrate themes in fields like Cell, Stomach, Lung and Loss of heterozygosity.
His most cited work include:
- Integrated molecular analysis of clear-cell renal cell carcinoma. (640 citations)
- Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca 2+ and AMPK/SIRT1 (640 citations)
- Pan-cancer analysis of whole genomes (538 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Pathology, Cancer research, Internal medicine, Immunohistochemistry and Cancer.
Masashi Fukayama combines subjects such as Lung and Adenocarcinoma with his study of Pathology.
His Cancer research research includes elements of DNA methylation, Carcinogenesis, Cancer cell, Epstein–Barr virus and microRNA.
His research integrates issues of Methylation and Epigenetics in his study of DNA methylation.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology and Oncology.
He is involved in the study of Cancer that focuses on Metastasis in particular.
He most often published in these fields:
- Pathology (48.60%)
- Cancer research (22.07%)
- Internal medicine (20.11%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (20.11%)
- Cancer research (22.07%)
- Pathology (48.60%)
In recent papers he was focusing on the following fields of study:
Masashi Fukayama mainly investigates Internal medicine, Cancer research, Pathology, Cancer and Gastroenterology.
The study incorporates disciplines such as Oncology and Cardiology in addition to Internal medicine.
His Cancer research study incorporates themes from Cancer cell, Epstein-Barr virus associated gastric carcinoma and Adenocarcinoma.
His studies link Mdm2 with Pathology.
His Cancer study integrates concerns from other disciplines, such as Cell culture, Antibody, Cadherin and Immune system.
His Gastroenterology study also includes
- Colorectal cancer together with Risk factor, Ulcerative colitis, Pathological, Chemoradiotherapy and Radiology,
- Dysplasia that intertwine with fields like Adenoma.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents. (84 citations)
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity (54 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Masashi Fukayama focuses on Cancer research, Pathology, Cancer, Internal medicine and Cancer cell.
His biological study spans a wide range of topics, including Virus, microRNA, Methylation and Epstein-Barr virus associated gastric carcinoma.
In the subject of general Pathology, his work in Malignant peripheral nerve sheath tumor is often linked to Operating procedures, thereby combining diverse domains of study.
His work on Predictive marker as part of his general Cancer study is frequently connected to Fusion protein, thereby bridging the divide between different branches of science.
His Internal medicine research incorporates elements of Gastroenterology and Diabetes mellitus, Insulin resistance.
His Cancer cell research includes themes of Epithelial–mesenchymal transition, Tumor necrosis factor alpha, PDPN, Podoplanin and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
